| Literature DB >> 334212 |
S Larsen, L Vejtorp, P Hornnes, H Bechgaard, L Sestoft, J Lyngsoe.
Abstract
1 In a single-blind, cross-over study fenfluramine in a daily dose of 120 mg was found to reduce the daily blood glucose level moderately in hospitalized obese diabetics treated with a 1200 calorie diabetic diet. 2 After 7 days of treatment, fenfluramine was found not to influence the intravenous glucose tolerance, the insulin response to intravenously administered glucose, or the growth hormone response to arginine. 3 No changes in blood levels of lactate, beta hydroxybutyrate, triglycerides or cholesterol were seen during fenfluramine treatment.Entities:
Mesh：
Substances：
Year: 1977 PMID： 334212 PMCID： PMC1429146 DOI： 10.1111/j.1365-2125.1977.tb00781.x
Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335